Tengvall, S., Lundqvist, A., Eisenberg, R. J., Cohen, G. H., & Harandi, A. M. (2006). Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves as a Potent Th1-Tilting Adjuvant for Recombinant gD2 Protein Vaccination against Genital Herpes. American Society for Microbiology.
Chicago Style CitationTengvall, Sara, Annika Lundqvist, Roselyn J. Eisenberg, Gary H. Cohen, i Ali M. Harandi. Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves As a Potent Th1-Tilting Adjuvant for Recombinant GD2 Protein Vaccination against Genital Herpes. American Society for Microbiology, 2006.
Cita MLATengvall, Sara, et al. Mucosal Administration of CpG Oligodeoxynucleotide Elicits Strong CC and CXC Chemokine Responses in the Vagina and Serves As a Potent Th1-Tilting Adjuvant for Recombinant GD2 Protein Vaccination against Genital Herpes. American Society for Microbiology, 2006.